Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis
Jing Li(University of Virginia), Weibin Shi(University of Virginia)
Cited by 12
Related Papers
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
|Nature Communications|2019|72
White matter integrity mediates the associations between white matter hyperintensities and cognitive function in patients with silent cerebrovascular diseases
|CNS Neuroscience & Therapeutics|2022|11
VirusImmu: a novel ensemble machine learning approach for viral immunogenicity prediction
|bioRxiv (Cold Spring Harbor Laboratory)|2023|3